Saffron Stress Meta-analysis: What the Evidence Says
Saffron Stress Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic
Quick Answer
Saffron Stress Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 preclinical study.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Saffron Stress Meta-analysis: What the Evidence Says
Quick Answer
Saffron Stress Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. | systematic review | 1 | 2025-11-19 | 10.1016/j.jtcme.2025.11.001 |
| The Role of Saffron in the Treatment of Depression: A Literature Review | preclinical study | 4 | 2026-03-03 | 10.7759/cureus.104594 |
What The Sources Report
- Background and aim Interest of herbal supplements as alternatives to conventional treatments for erectile dysfunction (ED) has increased markedly. [Ho CY (2025); evidence level 1]
- Results and conclusion Fourteen RCTs with a total of 1227 males with ED were included. [Ho CY (2025); evidence level 1]
- Depression is a leading cause of disability worldwide and is characterised by sustained low mood, anhedonia, anergia, and a range of associated cognitive and somatic symptoms . [Muacevic Alexander (2026); evidence level 4]
- This literature review summarises key randomised controlled trials (RCTs), meta-analyses, safety data, dosing patterns, and guideline positioning for saffron in depressive disorders, with emphasis on adult major depressive disorder (MDD) and related depressive symptomatology. [Muacevic Alexander (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For saffron stress meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Ho CY (2025). Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials.. DOI: 10.1016/j.jtcme.2025.11.001. PMCID: PMC12902307. PMID: 41696741. https://pmc.ncbi.nlm.nih.gov/articles/PMC12902307/
- Muacevic Alexander (2026). The Role of Saffron in the Treatment of Depression: A Literature Review. DOI: 10.7759/cureus.104594. PMCID: PMC13044667. PMID: 41939549. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13044667/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed June 25, 2026 by Migaku Evidence Review
